BACKGROUND: Imipenem-resistant Pseudomonas aeruginosa (IRPA) is an emerging problem. The causal role of antibiotic selective pressure versus patient-to-patient transmission has not been assessed using a large cohort. METHODS: Patients who were admitted to the medical and surgical intensive care units (ICUs) at the University of Maryland Medical Center from 2001 through 2006 had multiple perianal culture samples collected. Using pulsed-field gel electrophoresis (PFGE), the number of patients who acquired IRPA as a result of patient-to-patient transmission was determined. We also analyzed a subset of patients who had a previous surveillance culture that grew an imipenem-susceptible P. aeruginosa (ISPA) and a subsequent culture that grew IRPA. RESULTS: Our cohort consisted of 7071 patients. Three hundred patients were colonized with IRPA. 151 patients had positive culture findings at ICU admission, and 149 patients acquired an IRPA. Among the patients who acquired IRPA, 46 (31%) had a PFGE pattern similar to that for another isolate, and 38 (26%) were found to be colonized with an ISPA on the basis of earlier culture results. Of the 38-patient subset, 28 (74%) had identical PFGE patterns. CONCLUSIONS: Our data showed that, of those cases of IRPA acquisition, 46 (31%) were defined as cases of patient-to-patient transmission, and 28 (19%) were cases of acquisition by the patients' endogenous flora.
BACKGROUND:Imipenem-resistant Pseudomonas aeruginosa (IRPA) is an emerging problem. The causal role of antibiotic selective pressure versus patient-to-patient transmission has not been assessed using a large cohort. METHODS:Patients who were admitted to the medical and surgical intensive care units (ICUs) at the University of Maryland Medical Center from 2001 through 2006 had multiple perianal culture samples collected. Using pulsed-field gel electrophoresis (PFGE), the number of patients who acquired IRPA as a result of patient-to-patient transmission was determined. We also analyzed a subset of patients who had a previous surveillance culture that grew an imipenem-susceptible P. aeruginosa (ISPA) and a subsequent culture that grew IRPA. RESULTS: Our cohort consisted of 7071 patients. Three hundred patients were colonized with IRPA. 151 patients had positive culture findings at ICU admission, and 149 patients acquired an IRPA. Among the patients who acquired IRPA, 46 (31%) had a PFGE pattern similar to that for another isolate, and 38 (26%) were found to be colonized with an ISPA on the basis of earlier culture results. Of the 38-patient subset, 28 (74%) had identical PFGE patterns. CONCLUSIONS: Our data showed that, of those cases of IRPA acquisition, 46 (31%) were defined as cases of patient-to-patient transmission, and 28 (19%) were cases of acquisition by the patients' endogenous flora.
Authors: P Berthelot; F Grattard; P Mahul; P Pain; R Jospé; C Venet; A Carricajo; G Aubert; A Ros; A Dumont; F Lucht; F Zéni; C Auboyer; J C Bertrand; B Pozzetto Journal: Intensive Care Med Date: 2001-03 Impact factor: 17.440
Authors: Heather P Green; Judith A Johnson; Jon P Furuno; Sandra M Strauss; Eli N Perencevich; Ebbing Lautenbach; Dong Lee; Anthony D Harris Journal: Infect Control Hosp Epidemiol Date: 2007-05-31 Impact factor: 3.254
Authors: X Bertrand; M Thouverez; D Talon; A Boillot; G Capellier; C Floriot; J P Hélias Journal: Intensive Care Med Date: 2001-08 Impact factor: 17.440
Authors: Anthony D Harris; Mamuka Kotetishvili; Simone Shurland; Judy A Johnson; J Glenn Morris; Lucia L Nemoy; J Kristie Johnson Journal: Am J Infect Control Date: 2007-03 Impact factor: 2.918
Authors: Ralf-Peter Vonberg; Anneke Wolter; Iris F Chaberny; Axel Kola; Stefan Ziesing; Sebastian Suerbaum; Petra Gastmeier Journal: Int J Hyg Environ Health Date: 2007-11-05 Impact factor: 5.840
Authors: A D Harris; E N Perencevich; J K Johnson; D L Paterson; J G Morris; S M Strauss; J A Johnson Journal: Clin Infect Dis Date: 2007-10-16 Impact factor: 9.079
Authors: Jennifer K Johnson; Sonia M Arduino; O Colin Stine; Judith A Johnson; Anthony D Harris Journal: J Clin Microbiol Date: 2007-09-19 Impact factor: 5.948
Authors: Jan Beyersmann; Petra Gastmeier; Hajo Grundmann; Sina Bärwolff; Christine Geffers; Martin Behnke; Henning Rüden; Martin Schumacher Journal: Am J Infect Control Date: 2008-03 Impact factor: 2.918
Authors: C Peña; A Guzmán; C Suarez; M A Dominguez; F Tubau; M Pujol; F Gudiol; J Ariza Journal: Antimicrob Agents Chemother Date: 2007-04-09 Impact factor: 5.191
Authors: Anthony D Harris; J Kristie Johnson; Kerri A Thom; Daniel J Morgan; Jessina C McGregor; Adebola O Ajao; Anita C Moore; Angela C Comer; Jon P Furuno Journal: Infect Control Hosp Epidemiol Date: 2011-07 Impact factor: 3.254
Authors: Tracy H Hazen; LiCheng Zhao; Jason W Sahl; Gwen Robinson; Anthony D Harris; David A Rasko; J Kristie Johnson Journal: Antimicrob Agents Chemother Date: 2014-01-06 Impact factor: 5.191
Authors: Lalena Wallace; Sean C Daugherty; Sushma Nagaraj; J Kristie Johnson; Anthony D Harris; David A Rasko Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191